Beone Medicines Ltd (ONC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,705,071 | 1,513,438 | 1,498,170 | 1,412,284 | 1,315,300 |
| Cost of Goods | 174,530 | 167,215 | 142,422 | 196,510 | 164,606 |
| Gross Profit | 1,530,541 | 1,346,223 | 1,355,748 | 1,215,774 | 1,150,694 |
| Operating Expenses | 1,206,024 | 1,096,536 | 1,171,135 | 1,053,170 | 1,063,415 |
| Operating Income | 325,047 | 249,902 | 185,035 | 163,114 | 87,885 |
| Interest Expense | 39,739 | 32,887 | 43,237 | 0 | 7,995 |
| Other Income | 27,151 | 42,200 | 7,443 | -15,950 | 19,659 |
| Pre-tax Income | 312,459 | 259,215 | 149,241 | 147,164 | 99,549 |
| Income Tax | 75,452 | 31,858 | 82,739 | 22,323 | 5,229 |
| Net Income Continuous | 237,007 | 227,357 | 66,502 | 124,841 | 94,320 |
| Net Income | $237,007 | $227,357 | $66,502 | $124,841 | $94,320 |
| EPS Basic Total Ops | 2.12 | 2.05 | 0.62 | 1.13 | 0.87 |
| EPS Basic Continuous Ops | 2.12 | 2.05 | 0.62 | 1.13 | 0.87 |
| EPS Diluted Total Ops | 2.05 | 1.96 | 0.59 | 1.09 | 0.84 |
| EPS Diluted Continuous Ops | 2.05 | 1.96 | 0.59 | 1.09 | 0.84 |
| EPS Diluted Before Non-Recurring Items | 2.05 | 1.96 | 0.58 | 1.09 | 0.84 |
| EBITDA(a) | $365,562 | $291,046 | $221,019 | $200,398 | $123,499 |